Explore more Articles in

Stock Sectors

Why Is Cogent Biosciences Stock Trading Higher On Monday? – Cogent Biosciences (NASDAQ:COGT)

Cogent Biosciences, Inc.‘s COGT bezuclastinib showed meaningful clinical benefit for patients with non-advanced systemic mastocytosis, a rare and debilitating immune disorder. With statistically significant improvements...

3 Bullish Setups to Watch in July Amid Seasonal Tailwinds

As the second half of the year begins, several bullish setups are emerging—each supported by seasonal patterns and historical data. is approaching multi-year highs...

The Energy Report: Listen to What OPEC Says

prices are shaking off a larger-than-expected OPEC production increase as the precious metals get hit by a ton of bricks after President Trump...

Why Is KalVista Pharmaceuticals Stock Soaring On Monday? – KalVista Pharma (NASDAQ:KALV)

The U.S. Food and Drug Administration (FDA) on Monday approved KalVista Pharmaceuticals Inc.’s KALV Ekterly (sebetralstat) for acute attacks of hereditary angioedema (HAE) in adult...
Energy Stocks

Natural Gas: Hotter July Forecasts May Test Storage and Supply Balance

The market continues to navigate a complex mix of seasonal demand patterns, weather volatility, and fluctuating supply and demand. To better understand where...
Energy Stocks

Natural Gas Prices Risk Further Decline Amid Rising Supply and Weak Demand

in the United States fell to $3.40/MMBtu, the lowest level in six weeks, due to increased production and subdued demand. Mild weather conditions...
Energy Stocks

Oil Gains May Be Short-Lived With OPEC+ Set to Raise Supply Again

The trade deal between the US and Vietnam boosted oil prices. However, with OPEC+ set to decide on August output levels, the move higher...
BioTech

How Zevra’s Miplyffa Could Transform Investment Strategies – Zevra Therapeutics (NASDAQ:ZVRA)

Zevra Therapeutics, Inc. ZVRA is turning a quiet FDA approval into a broader comeback story. HC Wainwright initiated coverage on the rare disease drugmaker...
BioTech

Merck’s Hypertension Drug On FDA Fast Track For Label Expansion – Merck & Co (NYSE:MRK)

The U.S. Food and Drug Administration (FDA) has accepted and granted priority review for Merck & Co. Inc.’s MRK new supplemental Biologics License Application...
BioTech

Lawmakers Investigate Whether Pfizer Delayed COVID-19 Vaccine Results For Political Reasons – Pfizer (NYSE:PFE)

The House Judiciary Committee has subpoenaed Dr. Philip Dormitzer, a former Pfizer Inc. PFE executive, in connection with an investigation into claims that the...
1...345...29Page 4 of 29

- A word from our sponsors -

Most Popular

Disclaimer: The content provided is for informational purposes only. We aim to keep the content current and accurate by updating it frequently. Sometimes the actual data can differ from what's stated on our website. Buttonwoodnews.com is an independent platform. While we are independent, we may be compensated for advertisements, sponsored products, or when you click on a link on our website. The contributors and authors are not registered or certified financial advisors. You should consult a financial professional before making any financial decisions.

Copyright © Button Wood News.